E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

NCT05686226 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Throat Cancer
Oropharynx Cancer
Anal Cancer
Vulva Cancer
Vaginal Cancer
Penile Cancer
Metastatic Cancer
HPV-Related Malignancy
HPV-Related Carcinoma
HPV-Related Cervical Carcinoma
HPV-Related Squamous Cell Carcinoma
HPV-Related Adenocarcinoma
HPV Positive Oropharyngeal Squamous Cell Carcinoma
HPV-Associated Vaginal Adenocarcinoma
HPV-Related Adenosquamous Carcinoma
HPV-Related Endocervical Adenocarcinoma
HPV-Related Anal Squamous Cell Carcinoma
HPV-Related Penile Squamous Cell Carcinoma
HPV-Related Vulvar Squamous Cell Carcinoma
HPV Positive Rectal Squamous Cell Carcinoma

Interventions

BIOLOGICAL: E7 TCR-T cells
DRUG: Aldesleukin

Sponsor

Christian Hinrichs

Collaborators

[object Object]
[object Object]